Worth Venture Partners’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-6,393	Closed	-$647K	–	165
2023 Q1	$647K	Buy	+6,393	New	+$647K	0.32%	73
2017 Q4	–	Sell	-11,469	Closed	-$702K	–	99
2017 Q3	$702K	Buy	+11,469	New	+$702K	0.61%	33